Received Jun 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 3 | Y006121 | OT |
No Additional AE/ No PQC; Caller states third dose administered was verified to be VAQTA and was noticed to be expired after administered to patient.; This spontaneous report was received from a medical assistant and refers to a(n) 9-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Historical drugs included Hepatitis A vaccine (unknown brand name) (lot # NB759), and Hepatitis A vaccine (unknown brand name) (lot # 77DFK). These vaccines were administered at inappropriate schedule, reported as: patient received two hepatitis A vaccines (unknown brand name) at another facility 5 months apart instead of 6 months as recommended. Concomitant therapies were not reported. On 06-Jun-2025, the patient with the third dose of Hepatitis A Vaccine, Inactivated (VAQTA), lot #Y006121, expiration date: 17-May-2025, 0.5 mL administered by intramuscular route for the treatment of vaccination (expired vaccine used). No additional adverse event reported (no adverse event).